LONDON: Smarttech247 (AIM: S247), a multi-award-winning provider of AI-enhanced cybersecurity services providing automated managed detection and response for a portfolio of international clients, has signed a new additional contract with an existing pharmaceuticals solutions client worth USD $2.1 million over three years.

The contract will utilise Smarttech247’s partnership agreement with Splunk Inc., which brings together  Smarttech247’s automation-driven and human-led VisionX managed detection and response (MDR) capabilities and Splunk’s powerful security information and event management (SIEM) technology solutions. This collaboration creates an enhanced platform that addresses the evolving needs of a complex and evolving threat landscape.

Raluca Saceanu, CEO of Smarttech247, commented: “A key pillar of our growth journey is our strategic tech alliances with leading security players that allow us to expand our portfolio internationally, as well as enhance our current solutions. Through our collaboration with Splunk, we can deliver a service that combines our MDR solutions with advanced SIEM technology, empowering our clientele to pinpoint threats with precision whilst optimising their security efficiency.

“As part of this strategy, we are thrilled to announce this most recent contract win with a pre-existing client, a large, pharmaceuticals solutions organisation. This milestone underscores the confidence in Smarttech247 and Splunk’s combined capabilities and our dedication to delivering leading cybersecurity solutions.”

Smarttech247 announces a strategic partnership with Abnormal Security